Generics 15

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Amoxicillin manufacturers

15 products found

Filters

Filters

Filters , active

Country of origin : Italy

Clear all

15 products found

amoxicillin + clavulanic acid

Injection 600 mg , 1200 mg , 2200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
United Arab Emirates
Manufacturer #17548
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in Europe, North America, and Asia for 100+ years. Main therapeutic areas include gastroenterology, anti-infectious drugs, inflammation and pain, and nutraceuticals. The main dosage forms are injectable, oral, and topical. They are produced in cGMP-compliant manufacture.

Manufacturer usually replies in 10 days

amoxicillin

Injection 250 mg , 500 mg , 1 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17548
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in Europe, North America, and Asia for 100+ years. Main therapeutic areas include gastroenterology, anti-infectious drugs, inflammation and pain, and nutraceuticals. The main dosage forms are injectable, oral, and topical. They are produced in cGMP-compliant manufacture.

Manufacturer usually replies in 10 days

amoxicillin + clavulanic acid

Sachets 875 mg + 125 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17543
A pharmaceutical manufacturer based in the EU selling its products in EU countries that is active for 30+ years. Key production lines are generic, medical devices, and nutraceuticals. Main therapy areas include Bone disease, anti-bacterial, and diabetes. Do not work with bulk requests.

Manufacturer usually replies in 8 days

amoxicillin + clavulanic acid

Sachets 875 mg + 125 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #17543
A pharmaceutical manufacturer based in the EU selling its products in EU countries that is active for 30+ years. Key production lines are generic, medical devices, and nutraceuticals. Main therapy areas include Bone disease, anti-bacterial, and diabetes. Do not work with bulk requests.

Manufacturer usually replies in 8 days

amoxicillin

Tablets 1 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17543
A pharmaceutical manufacturer based in the EU selling its products in EU countries that is active for 30+ years. Key production lines are generic, medical devices, and nutraceuticals. Main therapy areas include Bone disease, anti-bacterial, and diabetes. Do not work with bulk requests.

Manufacturer usually replies in 8 days

amoxicillin

Granules for oral suspension 250 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17473
A pharmaceutical manufacturer based in the EU that is active in 40+ countries worldwide selling its products in Europe, the Middle East, LATAM, and Asia for 50+ years. The company has partnerships in the EU for production that comply with GMP standards. Key production lines include pharmaceutical products, nutraceuticals, medical devices, and cosmetics. Therapy areas include anti-infectives, anti-inflammatory and dermatological. The company has its R&D and regulatory affairs department for CTD dossier and marketing authorization management.

Manufacturer usually replies in 5 days

amoxicillin + clavulanic acid

Tablets, film coated 875 mg + 125 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
France , Germany , Lithuania , Poland , Vietnam
Manufacturer #17473
A pharmaceutical manufacturer based in the EU that is active in 40+ countries worldwide selling its products in Europe, the Middle East, LATAM, and Asia for 50+ years. The company has partnerships in the EU for production that comply with GMP standards. Key production lines include pharmaceutical products, nutraceuticals, medical devices, and cosmetics. Therapy areas include anti-infectives, anti-inflammatory and dermatological. The company has its R&D and regulatory affairs department for CTD dossier and marketing authorization management.

Manufacturer usually replies in 5 days

amoxicillin + clavulanic acid

Oral suspension 875 mg + 125 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Distribution only
Manufacturer #12969
It is a pharmaceutical company run by a family. It is a forward-thinking entrepreneurial and manufacturing company that is expanding in tandem with the growth of drug alternatives (generics) in Europe and around the world. It sells generic prescription drugs under its brand name (branded generics) in both common and specialty forms, as well as branded OTC medicines, medical devices, and food supplements across the country.

Manufacturer usually replies in 7 days

amoxicillin + clavulanic acid

Tablets, film coated 875 mg + 125 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Distribution only
Manufacturer #12969
It is a pharmaceutical company run by a family. It is a forward-thinking entrepreneurial and manufacturing company that is expanding in tandem with the growth of drug alternatives (generics) in Europe and around the world. It sells generic prescription drugs under its brand name (branded generics) in both common and specialty forms, as well as branded OTC medicines, medical devices, and food supplements across the country.

Manufacturer usually replies in 7 days

amoxicillin

Tablets, soluble 1 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Distribution only
Manufacturer #12969
It is a pharmaceutical company run by a family. It is a forward-thinking entrepreneurial and manufacturing company that is expanding in tandem with the growth of drug alternatives (generics) in Europe and around the world. It sells generic prescription drugs under its brand name (branded generics) in both common and specialty forms, as well as branded OTC medicines, medical devices, and food supplements across the country.

Manufacturer usually replies in 7 days

amoxicillin

Tablets, soluble 1 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #610
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in EU, Middle East, LATAM, CIS, and Asia for 20+ years. Key production lines are Rx, nutraceuticals, and dermo-cosmetics. Main therapeutic areas include CNS, antibiotics, and the cardiovascular system.

Manufacturer usually replies in 6 days

amoxicillin + clavulanic acid

Tablets 875 mg + 125 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #610
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in EU, Middle East, LATAM, CIS, and Asia for 20+ years. Key production lines are Rx, nutraceuticals, and dermo-cosmetics. Main therapeutic areas include CNS, antibiotics, and the cardiovascular system.

Manufacturer usually replies in 6 days

amoxicillin + clavulanic acid

Powder for oral suspension 400 mg/5 ml + 57 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #29017

Manufacturer usually replies in nan days

amoxicillin + clavulanic acid

Sachets 875 mg + 125 mg, 400 mg + 57 mg,400 mg + 57 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #29017

Manufacturer usually replies in nan days

amoxicillin + clavulanic acid

Tablets, film coated 875 mg + 125 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #29017

Manufacturer usually replies in nan days

Amoxicillin manufacturers

What is Amoxicillin?

Amoxicillin is an antibiotic. Amoxicillin works by inhibiting penicillin-binding proteins and high molecular weight penicillin-binding protein. Amoxicillin is used to treat bacterial infections, such as ear, nose or throat infections, urinary tract infections, skin infections, and pneumonia (lower respiratory tract). Amoxicillin can also be used for the medical treatment of acute otitis media, streptococcal pharyngitis, Salmonella infections, Lyme disease, and chlamydia infections.
If Amoxicillin is administered in combination with another medication, it can treat other infections. Amoxicillin and Clavulanic Acid can be used to treat acute bacterial sinusitis, community-acquired pneumonia, and lower respiratory tract infections. If Amoxicillin is given in combination with Omeprazole, it can be used for the treatment of H. pylori.
Amoxicillin was discovered in 1958 at Beecham, England. Amoxicillin was approved for medical use in 1972 in the UK. In 1974, the FDA approved the medical use of Amoxicillin; Amoxicillin is on the World Health Organization's List of Essential Medicines.

How to use Amoxicillin?

To treat chlamydia infection, an adult patient should take 500 mg of Amoxicillin orally three times a day for seven days.
To treat helicobacter pylori infection, a patient can choose between a dual or triple therapy. For the dual therapy, the adult patient should take 1 g orally every 8 hours for 14 days in combination with lansoprazole and for the triple therapy, an adult patient should take 1 g orally every 12 hours for 14 days in combination with clarithromycin and lansoprazole.
To treat mild, moderate, or severe pneumonia or bronchitis, an adult patient should take 500 mg of Amoxicillin orally every 8 hours or 875 mg every 12 hours. To treat mild to moderate sinusitis, skin infection, or urinary tract infection, an adult patient should take 250 mg of Amoxicillin orally every 8 hours or 500 mg every 12 hours, and for severe infection, the patient should take 500 mg of Amoxicillin every 8 hours or 875 mg every 12 hours.
Taking Amoxicillin can cause side effects, such as nausea, diarrhea, rash, headache, heavier menstrual periods, unusual or unpleasant (after-) taste, and general body swelling.
It is recommended to take Amoxicillin with food.

Amoxicillin manufacturers and suppliers

Amoxicillin's most known brand names are Amoxil, Trimox, and Moxatag. However, Amoxicillin patents have already expired, and generic versions of the drug are widely available. Since the patent date has already expired, many Amoxicillin manufacturers around the globe actively manufacture this penicillin antibiotic.
Amoxicillin's other trade names are Actimoxi, Amoclen, Amolin, Amopen, Amopenixin, Amoxibiotic, Clamoxyl, Efpenix, Flemoxin, Hiconcil, Biamox, Moxal, Ospamox, Pamoxicillin, Polymox, Wymox.
Some of the Amoxicillin manufacturers are Dr. Reddy's Laboratories, Inc, Sandoz Inc, Teva Pharmaceuticals USA, Inc, West-Ward Pharmaceuticals, NorthStar Rx LLC, Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC.
Amoxicillin suppliers market it in the form of 250 mg, 500 mg oral capsules, 25 mg/ 1 ml, 50 mg/1 ml, 125 mg/5 ml oral suspensions, 500 mg, 875 mg film-coated tablets, 125 mg, 200 mg, 250 mg chewable tablets, 400 mg/ 5 ml, 250 mg/5 ml, 125 mg / 5ml, 200 mg/5 ml powder for suspension.

Amoxicillin for sales

The Amoxicillin patent has expired, and many manufacturers produce this medication on a high scale. For those reasons, Amoxicillin prices are quite low. However, Amoxicillin costs depend on the country where it is sold and the health policies of the country.
In the US the prices are the following:
  • For a 500 mg Amoxicillin tablet, it costs from $0.26 to $0.64, and for an 875 mg tablet, Amoxicillin costs from $0.12 to $0.50 per unit.
  • For a 125 mg chewable tablet, Amoxicillin costs about $0.57 per tablet, and for a 250 mg chewable tablet, Amoxicillin costs from $0.47 to $2.63.
  • For a 250 mg capsule, Amoxicillin costs from $0.11 to $2.39 per capsule, and for a 50 mg capsule, Amoxicillin costs from $0.25 to $2.45 per unit.
  • Under the final dosage form of 400 mg/ 5 ml powder for oral suspension, Amoxicillin costs from $0.10 to $0.19 per unit.
  • For a 250 mg/5 ml it costs from $0.08 to $0.13, for a 200 mg/5 ml, Amoxicillin costs from $0.12 to $0.21.
  • For a 125 mg / 5ml powder for oral suspension, Amoxicillin costs from $0.08 to $0.13 per unit.

Connect with Amoxicillin manufacturers directly

As Amoxicillin is a globally found drug, on the internet you can encounter fraudulent websites that will want to sell Amoxicillin with some risks for you and your clients.
By using the Pipelinepharma B2B marketplace, you avoid time-consuming sourcing. We can directly connect you with qualified Amoxicillin sellers screened based on our proven quality control procedures.
On the online platform, Amoxicillin is mostly available from the EU, the UK, Israel, Kosovo, India, Australia, Brazil, Switzerland, Turkey, Malaysia, Jordan, Indonesia, China, and South Korea.
Thanks to the intuitive online marketplace, you will find Amoxicillin and many other drugs quickly and efficiently. Placing an inquiry has never been easier than with Pipelinepharma. Let us connect you with Amoxicillin manufacturers wherever they are in the world.
Not only is this marketplace a good choice for distributors and other buyers, but pharma sellers and manufacturers benefit as well. They can register and list an unlimited number of pharmaceutical products free of charge.